{"id":25034,"date":"2026-02-25T08:42:45","date_gmt":"2026-02-25T06:42:45","guid":{"rendered":"https:\/\/ibsal.es\/evento\/horizon-europe-cancer-mission-2026-and-2027\/"},"modified":"2026-02-25T08:42:45","modified_gmt":"2026-02-25T06:42:45","slug":"horizon-europe-cancer-mission-2026-and-2027","status":"publish","type":"tribe_events","link":"https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/","title":{"rendered":"Horizon Europe. Cancer Mission 2026 and 2027"},"content":{"rendered":"<h3 style=\"color: #003c8c;\">Features<\/h3>\n<p>The work program for the  <a href=\"https:\/\/research-and-innovation.ec.europa.eu\/funding\/funding-opportunities\/funding-programmes-and-open-calls\/horizon-europe\/horizon-europe-work-programmes_en\">Cancer Missions under Horizon Europe for 2026 and 2027.<\/a><\/p>\n<p>These are single-phase calls for proposals, aimed at international multidisciplinary consortia, which must submit a proposal in accordance with the specifications for each topic.<\/p>\n<p>Admission requirements, eligibility criteria, and the necessary documents are described in the <a href=\"https:\/\/research-and-innovation.ec.europa.eu\/funding\/funding-opportunities\/funding-programmes-and-open-calls\/horizon-europe\/horizon-europe-work-programmes_en\">General Annexes.<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>These are the topics included in the Cancer Mission\u2019s new Work Program <span style=\"color: #0000ff;\"><strong>for the year 2026:<\/strong><\/span><\/p>\n<p><strong>These topics are single-phase: they begin on February 10, 2026, and end on September 15, 2026.<\/strong><\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2026-02-CANCER-02: Microbiome for Early Cancer Prediction Before the Onset of Disease<\/p>\n<div class=\"agenda-details-rgt noticia\">\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimize immunotherapy interventions for patients with refractory cancers<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2026-02-CANCER-04: Earlier and More Precise Palliative Care<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2026-02-CANCER-05: Improving the mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity-building program on cancer with and for Ukraine (csa)<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of Older Cancer Patients<\/p>\n<\/div>\n<p><strong>A very interesting topic in the &#8220;Soil Deal for Europe&#8221; section, which opens on February 4, 2026, and closes on September 23, 2026:<\/strong><\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2026-05-SOIL-02: Antimicrobial Resistance and Antibiotic Biosynthesis in Soils: Developing Key Insights and Countermeasures Using a One-Health Approach<\/p>\n<p>&nbsp;<\/p>\n<p>These are the topics included in the Cancer Mission\u2019s new Work Program <span style=\"color: #0000ff;\"><strong>for the year 2027:<\/strong><\/span><\/p>\n<p><strong>These topics are single-phase: they begin on February 10, 2027, and end on September 21, 2027.<\/strong><\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to identify novel targets for cancer treatment<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2027-02-CANCER-02: Clinical research conducted by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2027-02-CANCER-03: Phase 1, including first-in-human clinical trials to test biomarker-guided medicines or multimodal treatment interventions for patients with rare or very rare cancers or cancer subtypes<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health economics research, health systems research, and outcomes research<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2027-02-CANCER-05: Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines<\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2027-02-CANCER-06: Support for a research program on the quality of life (QoL) of young cancer survivors, led by cancer charities and funding agencies (csa)<\/p>\n<p><strong>This is a very interesting topic\u2014a Joint Call for Missions. The call opens on February 4, 2027, and closes on September 21, 2027:<\/strong><\/p>\n<p style=\"padding-left: 40px;\">HORIZON-MISS-2027-06-SOIL-CANCER: Living labs to monitor and mitigate carcinogenic substances in and originating from soils: Evaluating their effects on human cancer risks<\/p>\n<p>&nbsp;<\/p>\n<p>**If you&#8217;re interested in any of our job openings or need more information, please don&#8217;t hesitate to contact us.<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<\/ul>\n<h3 style=\"color: #003c8c;\">Requirements:<\/h3>\n<p style=\"color: #003c8c;\">These calls for proposals are aimed at multidisciplinary European consortia. Unless otherwise specified in the specific conditions of the call, only legal entities that form a consortium will be eligible to participate in the actions, provided that the consortium includes, as beneficiaries, three legal entities that are independent of one another, each established in a different country, in accordance with the following criteria: <\/p>\n<ul data-start=\"514\" data-end=\"720\">\n<li data-start=\"514\" data-end=\"594\">\n<p data-start=\"516\" data-end=\"594\">at least one independent legal entity established in a Member State; and<\/p>\n<\/li>\n<li data-start=\"595\" data-end=\"720\">\n<p data-start=\"597\" data-end=\"720\">at least two other independent legal entities, each established in different Member States or Associated Countries.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"722\" data-end=\"877\" data-is-last-node=\"\" data-is-only-node=\"\">Legal entities established in Russia, Belarus, or in territories of Ukraine not controlled by the government are not eligible.<\/p>\n<h3 style=\"color: #003c8c;\">How to apply<\/h3>\n<p>Applications consist of two sections:<\/p>\n<p><strong>-Part A<\/strong> (to be completed online) contains administrative information related to the consortium, the budget, and specific details of the call for proposals.<\/p>\n<p><strong>-Part B<\/strong> (a template downloaded from the Commission&#8217;s website must be completed) contains the scientific and technical aspects of the project.<\/p>\n<p>&nbsp;<\/p>\n<h3 style=\"color: #003c8c;\">Submission deadline.<\/h3>\n<p>The 2026 application deadlines are September 15, and the process is a single-stage process,  <strong> <\/strong>With <strong>the exception<\/strong> of call HORIZON-MISS-2026-05-SOIL-02<strong>, which ends on September 23, 2026.<\/strong><\/p>\n<p>The application deadlines for 2027 are September 21, 2027, and the application process consists of a single stage.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Features The work program for the Cancer Missions under Horizon Europe for 2026 and 2027. These are single-phase calls for proposals, aimed at international multidisciplinary consortia, which must submit a [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"template":"","meta":{"_acf_changed":false,"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"_tribe_events_status":"","_tribe_events_status_reason":"","_tribe_events_is_hybrid":"","_tribe_events_is_virtual":"","_tribe_events_virtual_video_source":"","_tribe_events_virtual_embed_video":"","_tribe_events_virtual_linked_button_text":"","_tribe_events_virtual_linked_button":"","_tribe_events_virtual_show_embed_at":"","_tribe_events_virtual_show_embed_to":[],"_tribe_events_virtual_show_on_event":"","_tribe_events_virtual_show_on_views":"","_tribe_events_virtual_url":"","footnotes":"","_members_access_role":[],"_members_access_error":"","_tec_slr_enabled":"","_tec_slr_layout":""},"tags":[],"tribe_events_cat":[256],"class_list":["post-25034","tribe_events","type-tribe_events","status-publish","hentry","tribe_events_cat-calls-for-research","cat_calls-for-research"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.12 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Horizon Europe. Cancer Mission 2026 and 2027 | IBSAL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Horizon Europe. Cancer Mission 2026 and 2027\" \/>\n<meta property=\"og:description\" content=\"Features The work program for the Cancer Missions under Horizon Europe for 2026 and 2027. These are single-phase calls for proposals, aimed at international multidisciplinary consortia, which must submit a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/\" \/>\n<meta property=\"og:site_name\" content=\"IBSAL\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibsal.es\/wp-content\/uploads\/2024\/10\/Snippet.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/horizon-europe-cancer-mission-2026-and-2027\\\/\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/horizon-europe-cancer-mission-2026-and-2027\\\/\",\"name\":\"Horizon Europe. Cancer Mission 2026 and 2027 | IBSAL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\"},\"datePublished\":\"2026-02-25T06:42:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/horizon-europe-cancer-mission-2026-and-2027\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/horizon-europe-cancer-mission-2026-and-2027\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/horizon-europe-cancer-mission-2026-and-2027\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibsal.es\\\/en\\\/institute-of-biomedical-research-of-salamanca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/ibsal.es\\\/en\\\/eventss\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Horizon Europe. Cancer Mission 2026 and 2027\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/\",\"name\":\"IBSAL\",\"description\":\"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n\",\"alternateName\":\"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibsal.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Horizon Europe. Cancer Mission 2026 and 2027 | IBSAL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/","og_locale":"en_US","og_type":"article","og_title":"Horizon Europe. Cancer Mission 2026 and 2027","og_description":"Features The work program for the Cancer Missions under Horizon Europe for 2026 and 2027. These are single-phase calls for proposals, aimed at international multidisciplinary consortia, which must submit a [&hellip;]","og_url":"https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/","og_site_name":"IBSAL","og_image":[{"width":1200,"height":675,"url":"https:\/\/ibsal.es\/wp-content\/uploads\/2024\/10\/Snippet.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/","url":"https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/","name":"Horizon Europe. Cancer Mission 2026 and 2027 | IBSAL","isPartOf":{"@id":"https:\/\/ibsal.es\/en\/#website"},"datePublished":"2026-02-25T06:42:45+00:00","breadcrumb":{"@id":"https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibsal.es\/en\/evento\/horizon-europe-cancer-mission-2026-and-2027\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibsal.es\/en\/institute-of-biomedical-research-of-salamanca\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/ibsal.es\/en\/eventss\/"},{"@type":"ListItem","position":3,"name":"Horizon Europe. Cancer Mission 2026 and 2027"}]},{"@type":"WebSite","@id":"https:\/\/ibsal.es\/en\/#website","url":"https:\/\/ibsal.es\/en\/","name":"IBSAL","description":"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n","alternateName":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibsal.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"ticketed":false,"_links":{"self":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events\/25034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/users\/16"}],"version-history":[{"count":0,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events\/25034\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/media?parent=25034"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tags?post=25034"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events_cat?post=25034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}